DYADIC INTERNATIONAL INC DYAI 深 滬
已收盤 08-08 16:00:00 美东时间
0.937
-0.013
-1.36%
華盛通- 最 高0.9675
- 今 開0.9501
- 成交量 9.19万股
- 最 低 0.91
- 昨 收 0.9499
- 總市值 2819.50万
- 52周最高 2.20
- 市盈率 靜 --
- 換手率 0.31%
- 52周最低 0.91
- 委 比 -80.18%
- 總股本 3009.07万
- 歷史最高 10.98
- 量 比 1.22
- 振 幅 6.05%
- 歷史最低 0.91
- 每 手 1
- 風險率 0.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
Dyadic International, a global biotechnology company, announced it will report its second quarter 2025 financial results and host a corporate update conference call on August 13, 2025, at 5:00 p.m. Eastern Time. Participants can join via phone toll-free: +1-877-407-0784 or international: +1-201-689-8560, using conference ID 13751388. A live webcast will be available at https://viavid.webcasts.com/starthere.jsp?ei=1706019&tp_key=4747da0ef3, with a...
08-05 20:11
Dyadic International Closes $5.3 Million Stock Offering
An announcement from Dyadic International ( ($DYAI) ) is now available. On July...
08-02 05:03
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) stock rose 21.4% to $1.05 during Wednesday'...
07-31 05:06
Dyadic International Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life
07-31 04:22
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
Dyadic International, a global biotechnology company, has initiated an underwritten public offering of its common stock, with Craig-Hallum Capital Group serving as the sole managing underwriter. The offering is subject to market conditions, and proceeds will be used for working capital, product development, and other general corporate purposes. The offering is registered under SEC’s Form S-3, and a prospectus supplement will be filed.
07-30 20:02
Dyadic International Shifts Focus to Commercial Enterprise
Dyadic International ( ($DYAI) ) has shared an update. On July 23, 2025, Dyadic...
07-24 05:48
Dyadic International Announces Strategic Rebranding Initiative
Dyadic International ( ($DYAI) ) has shared an announcement. On July 2, 2025, D...
07-03 04:49
Dyadic International Receives Nasdaq Deficiency Notice
Dyadic International ( ($DYAI) ) has shared an update. On June 23, 2025, Dyadic...
06-28 04:17
Dyadic International Announces COO Joe Hazelton Appointed As President, Effective Immediately
Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team realigned in order to enable execution of ancillary protein strategyDyadic is well
06-02 20:39
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
Dyadic International updated its leadership structure, appointing Joe Hazelton as President to enhance its ancillary recombinant protein strategy. The company has successfully validated its approach through key partnerships in high-growth markets. With a focus on commercialization, Dyadic aims to leverage geopolitical trends for supply chain reshoring and expand its microbial protein production platforms across life sciences, nutrition, and indus...
06-02 12:35
